In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 |
---|---|---|
Revenue | 430,500 |
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Macro Group Pharmaceutical‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Hisham Wasfy | Chief Executive Officer & Board Member | ||
Ashraf Hamdy | Chief Financial Officer | ||
Ahmed El Nayeb | Co-Founder & Group Chairman |
Name | Representing | Role | Since |
---|---|---|---|
000000 00000 | Alta Semper Capital | Board Member | 000 0000 |
00000 00 00000 | Macro Group Pharmaceutical | Co-Founder & Group Chairman | 000 0000 |
00000 0000 | Alta Semper Capital | Vice Chairman of the Board | 000 0000 |
000000 00000 | Macro Group Pharmaceutical | Chief Executive Officer & Board Member | 000 0000 |
000000 00000000 | Alta Semper Capital | Board Member | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Macro Group Pharmaceutical‘s full profile, request access.
Request a free trial